Zitnik R - Search Results

1

Etanercept as monotherapy in patients with psoriasis.

Leonardi CL, Powers JL, Matheson RT, Goffe BS, Zitnik R, Wang A, Gottlieb AB; Etanercept Psoriasis Study Group. Leonardi CL, et al. Among authors: zitnik r. N Engl J Med. 2003 Nov 20;349(21):2014-22. doi: 10.1056/NEJMoa030409. N Engl J Med. 2003. PMID: 14627786 Clinical Trial.

2

Modeling the exposure-response relationship of etanercept in the treatment of patients with chronic moderate to severe plaque psoriasis.

Hutmacher MM, Nestorov I, Ludden T, Zitnik R, Banfield C. Hutmacher MM, et al. Among authors: zitnik r. J Clin Pharmacol. 2007 Feb;47(2):238-48. doi: 10.1177/0091270006295062. J Clin Pharmacol. 2007. PMID: 17244775

3

Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis.

Nestorov I, Zitnik R, DeVries T, Nakanishi AM, Wang A, Banfield C. Nestorov I, et al. Among authors: zitnik r. Br J Clin Pharmacol. 2006 Oct;62(4):435-45. doi: 10.1111/j.1365-2125.2006.02581.x. Br J Clin Pharmacol. 2006. PMID: 16995864 Free PMC article. Clinical Trial.

4

Etanercept monotherapy in patients with psoriasis: a summary of safety, based on an integrated multistudy database.

Gottlieb AB, Leonardi CL, Goffe BS, Ortonne JP, van der Kerkhof PC, Zitnik R, Nakanishi A, Jahreis A. Gottlieb AB, et al. Among authors: zitnik r. J Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S92-100. doi: 10.1016/j.jaad.2005.10.053. J Am Acad Dermatol. 2006. PMID: 16488335

5

Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trial.

Krueger GG, Elewski B, Papp K, Wang A, Zitnik R, Jahreis A. Krueger GG, et al. Among authors: zitnik r. J Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S112-9. doi: 10.1016/j.jaad.2005.10.054. J Am Acad Dermatol. 2006. PMID: 16488321

6

Efficacy of etanercept in an integrated multistudy database of patients with psoriasis.

Gordon K, Korman N, Frankel E, Wang H, Jahreis A, Zitnik R, Chang T. Gordon K, et al. Among authors: zitnik r. J Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S101-11. doi: 10.1016/j.jaad.2005.11.1088. J Am Acad Dermatol. 2006. PMID: 16488320

7

Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy.

Gordon KB, Gottlieb AB, Leonardi CL, Elewski BE, Wang A, Jahreis A, Zitnik R. Gordon KB, et al. Among authors: zitnik r. J Dermatolog Treat. 2006;17(1):9-17. doi: 10.1080/09546630500472838. J Dermatolog Treat. 2006. PMID: 16467018 Clinical Trial.

8

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R, Cella D, Krishnan R. Tyring S, et al. Among authors: zitnik r. Lancet. 2006 Jan 7;367(9504):29-35. doi: 10.1016/S0140-6736(05)67763-X. Lancet. 2006. PMID: 16399150 Clinical Trial.

9

Population pharmacokinetic modeling of subcutaneously administered etanercept in patients with psoriasis.

Nestorov I, Zitnik R, Ludden T. Nestorov I, et al. Among authors: zitnik r. J Pharmacokinet Pharmacodyn. 2004 Dec;31(6):463-90. doi: 10.1007/s10928-005-5912-0. J Pharmacokinet Pharmacodyn. 2004. PMID: 16222785

10

No evidence for increased risk of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis receiving etanercept for up to 5 years.

Lebwohl M, Blum R, Berkowitz E, Kim D, Zitnik R, Osteen C, Wallis WJ. Lebwohl M, et al. Among authors: zitnik r. Arch Dermatol. 2005 Jul;141(7):861-4. doi: 10.1001/archderm.141.7.861. Arch Dermatol. 2005. PMID: 16027301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results